Literature DB >> 697138

German Shepherd dog myelopathy--a morphologic and morphometric study.

K G Braund, M Vandevelde.   

Abstract

The concept that a degenerative neurologic disease in German Shepherd Dogs (designated "German Shepherd Dog myelopathy") represents a dying-back disease process was not substantiated by morphologic and morphometric data derived from central and peripheral nervous system evaluation in 23 dogs. The occurrence of this identifiable disease complex in German Shepherd Dogs suggested a role by genetic determinants.

Entities:  

Mesh：

Year:  1978        PMID： 697138

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN： 0002-9645            Impact factor:   1.156


  8 in total

Review 1.  Abiotrophy in domestic animals: a review.

Authors:  A de Lahunta
Journal:  Can J Vet Res       Date:  1990-01       Impact factor: 1.310

2.  Genome-wide association analysis reveals a SOD1 mutation in canine degenerative myelopathy that resembles amyotrophic lateral sclerosis.

Authors:  Tomoyuki Awano; Gary S Johnson; Claire M Wade; Martin L Katz; Gayle C Johnson; Jeremy F Taylor; Michele Perloski; Tara Biagi; Izabella Baranowska; Sam Long; Philip A March; Natasha J Olby; G Diane Shelton; Shahnawaz Khan; Dennis P O'Brien; Kerstin Lindblad-Toh; Joan R Coates
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-02       Impact factor: 11.205

3.  Immunohistochemical evidence for immunoglobulin and complement deposition in spinal cord lesions in degenerative myelopathy in German shepherd dogs.

Authors:  K B Barclay; D M Haines
Journal:  Can J Vet Res       Date:  1994-01       Impact factor: 1.310

4.  A retrospective study of the prevalence of the canine degenerative myelopathy associated superoxide dismutase 1 mutation (SOD1:c.118G > A) in a referral population of German Shepherd dogs from the UK.

Authors:  Angela L Holder; James A Price; Jamie P Adams; Holger A Volk; Brian Catchpole
Journal:  Canine Genet Epidemiol       Date:  2014-09-25

5.  Cerebrospinal Fluid Levels of Phosphorylated Neurofilament Heavy as a Diagnostic Marker of Canine Degenerative Myelopathy.

Authors:  C M Toedebusch; M D Bachrach; V B Garcia; G C Johnson; M L Katz; G Shaw; J R Coates; M L Garcia
Journal:  J Vet Intern Med       Date:  2017-02-10       Impact factor: 3.333

6.  Retrospective Observational Study and Analysis of Two Different Photobiomodulation Therapy Protocols Combined with Rehabilitation Therapy as Therapeutic Interventions for Canine Degenerative Myelopathy.

Authors:  Lisa A Miller; Debbie Gross Torraca; Luis De Taboada
Journal:  Photobiomodul Photomed Laser Surg       Date:  2020-04

7.  Breed distribution of SOD1 alleles previously associated with canine degenerative myelopathy.

Authors:  R Zeng; J R Coates; G C Johnson; L Hansen; T Awano; A Kolicheski; E Ivansson; M Perloski; K Lindblad-Toh; D P O'Brien; J Guo; M L Katz; G S Johnson
Journal:  J Vet Intern Med       Date:  2014-02-13       Impact factor: 3.333

8.  Allele and genotype frequencies of the SOD1 gene polymorphism associated with canine degenerative myelopathy in Belgian Malinois dogs in Greece.

Authors:  Antonia Mataragka; John Ikonomopoulos; Georgios S Zervas; Christos D Vamvakidis; Nikolaos Tzimotoudis; Ariadne Loukia Hager-Theodorides; Maria Gazouli; Antonios Kominakis
Journal:  Vet World       Date:  2021-06-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.